Publicaciones en las que colabora con Julio López Abán (20)

2024

  1. Current drug strategies for the treatment and control of schistosomiasis

    Expert Opinion on Pharmacotherapy, Vol. 25, Núm. 4, pp. 409-420

2022

  1. Diseño y elaboración de rúbricas para la autoevaluación y evaluación de las actividades

    I Jornada de Innovación Docente de las Universidades Públicas de Castilla y León

  2. Evaluation of the Immunomodulatory Effect of the Recombinant 14-3-3 and Major Antigen Proteins of Strongyloides stercoralis against an Infection by S. venezuelensis

    Vaccines, Vol. 10, Núm. 8

  3. Modelo in vitro para evaluar la actividad de compuestos antiparasitarios frente a Trichinella spiralis

    XII Congreso de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)

2021

  1. T cell peptides derived from invasive stages of schistosoma mansoni as potential schistosomiasis vaccine

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-14

2019

  1. Diseño, síntesis y evaluación de amidas y sulfonamidas con actividad tipo colchicina contra Strongyloides venezuelensis

    XI Congreso de la Sociedad Española de Medicina Tropical y Salud Internacional (SEMTSI)

  2. Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis

    Frontiers in Immunology, Vol. 10

2018

  1. Electronic portfolio in a scientific methodology course at the Faculty of Pharmacyof the University of Salamanca

    IPAP 18 Innovations in Pharmacy: Advances and Perspectives

2017

  1. Transcriptome profiling of gene expression during immunisation trial against Fasciola hepatica: Identification of genes and pathways involved in conferring immunoprotection in a murine model

    BMC Infectious Diseases, Vol. 17, Núm. 1

2016

  1. Aza-polyheterocyclic compounds derived from antineoplastic and antiparasitic terpenylnapthquinones

    VIII Simpósio Iberoamericano de Plantas Medicinais (VIII SIPM) e III Simpósio Iberoamericano de Investigação em Câncer (III SIIC)

  2. In vitro and in vivo evaluation of 2-aminoalkanol and 1,2-alkanediamine derivatives against Strongyloides venezuelensis

    Parasites and Vectors, Vol. 9, Núm. 1

  3. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

    Parasites and Vectors, Vol. 9, Núm. 1

2015

  1. Actividad de aminoalcoholes y diaminas frente a Strongyloides venezuelensis

    XIX Congreso de la Sociedad Española de Parasitología (SOCEPA)

  2. The combination of the aliphatic diamine AA0029 in ADAD vaccination system with a recombinant fatty acid binding protein could be a good alternative for the animal schistosomiasis control

    Experimental Parasitology, Vol. 154, pp. 134-142

  3. Trypanocidal Activity of Long Chain Diamines and Aminoalcohols

    Molecules, Vol. 20, Núm. 6, pp. 11554-11568

2014

  1. In vitro and in vivo studies for assessing the immune response and protection-inducing ability conferred by Fasciola hepatica-derived synthetic peptides containing B- and T-cell epitopes

    PLoS ONE, Vol. 9, Núm. 8

2012

  1. Adaptive immune stimulation is required to obtain high protection with fatty acid binding protein vaccine candidate against fasciola hepatica in balb/C mice

    Journal of Parasitology, Vol. 98, Núm. 3, pp. 527-535

2010

  1. Vaccination against strongyloides venezuelensis with homologue antigens using new immunomodulators

    Journal of Parasitology, Vol. 96, Núm. 3, pp. 643-647

2007

  1. Genetic and immunological characterization of the 14-3-3ζ molecule from Schistosoma bovis

    Journal of Parasitology, Vol. 93, Núm. 4, pp. 964-969

  2. The Sb14-3-3ζ recombinant protein protects against Schistosoma bovis in BALB/c mice

    Vaccine, Vol. 25, Núm. 23, pp. 4533-4539